Mapping large numbers of results may take a few moments.
Search Results
Showing 1 - 23 of 23 results found.
| Company | Activity | Company Description | Location | |
|---|---|---|---|---|
|
Company BD Technologies and Innovation (RTP) | Activity: Research and Development | Company Description BD is a global medical technology company working to improve medical discovery, diagnostics and the delivery of care. The RTP site, established in 1972, is the North American hub of BD's global enterprise R&D network. | Location Research Triangle Park |
 |
Company Accord Healthcare Inc. | Activity: Sales and Operations | Company Description Accord Healthcare is the marketing subsidiary of Intas Pharmaceuticals, an India-based company that focuses on manufacturing generic pharmaceuticals and biosimilars for the global market. | Location Durham |
| |
Company Aerami Therapeutics | Activity: Research and Development | Company Description Aerami Therapeutics develops soft mist inhaled formulations of biologics and inhalation devices to treat severe and chronic diseases. Its first product is for the treatment of diabetes. | Location Durham |
| |
Company BioKier Inc. | Activity: Research and Development | Company Description BioKier develops proprietary adjuvant treatments for diabetes and related disorders. BioKier has identified a therapeutic opportunity based on gastric bypass surgery and is developing several novel treatments for cardiometabolic diseases including hyperlipidemia and insulin resistance. | Location Chapel Hill |
| |
Company Charles River Laboratories (Durham) | Activity: Contract Research and Testing | Company Description Charles River Laboratories' Oncology Center of Excellence provides in vivo and in vitro oncology and immuno-oncology research services. | Location Durham |
| |
Company Fervent Pharmaceuticals LLC | Activity: Research and Development | Company Description Fervent Pharmaceuticals develops a nonhormonal product, FP-101, to treat vasomotor symptoms associated with menopause. | Location Greenville |
| |
Company GeneType | Activity: Research and Development | Company Description GeneType develops genetic risk assessment tests to predict an individual's risk of developing chronic disease. | Location Charlotte |
| |
Company High Point Clinical Trials Center | Activity: Contract Research and Testing | Company Description High Point Clinical Trials Center conducts phase one and two clinical research studies to test emerging drugs for pharmaceutical companies. | Location High Point |
| |
Company Ideal Health Biotechnology LLC | Activity: Research and Development | Company Description Ideal Health Biotechnology researches and develops dietary supplements made from plant-based compounds, including products derived from grape seed extract and algae for digestion, eye disease and diabetes. | Location Kannapolis |
| |
Company Intarcia Therapeutics Inc. | Activity: Research and Development | Company Description Intarcia Therapeutics is developing a continuous subcutaneous delivery system for the treatment of Type 2 diabetes. The RTP location discovers and develops peptide therapeutic drugs to augment Intarcia's drug delivery platform. | Location Research Triangle Park |
| |
Company Kowa Research Institute Inc. | Activity: Research and Development | Company Description Kowa Research Institute, a division of Kowa Company Ltd., develops therapeutic drugs for the treatment of cardio-metabolic diseases such as diabetes and atherosclerosis, pain and sensory organ disorders. | Location Morrisville |
| |
Company Kriya Therapeutics Inc. | Activity: Production and Manufacturing | Company Description Kriya Therapeutics develops AAV-based gene therapies for the treatment of type 1 and type 2 diabetes, severe obesity, and other indications. This location is the company's internal manufacturing facility. | Location Morrisville |
| |
Company Marius Pharmaceuticals LLC | Activity: Research and Development | Company Description Marius Pharmaceuticals develops therapeutic treatments, with a focus on oral testosterone replacement therapies for adult men symptomatic of hypogonadism. | Location Raleigh |
| |
Company Metabolon Inc. | Activity: Contract Research and Testing | Company Description Metabolon is advancing the science of metabolomics for the clinic and life sciences research. Its technology and data are used for biomarker discovery, diagnostic test development, and genomics and population health initiatives. | Location Morrisville |
| |
Company Novo Nordisk Pharmaceutical Industries LP (API facility) | Activity: Production and Manufacturing | Company Description Novo Nordisk's Active Pharmaceutical Ingredient (API) facility produces the API for an oral diabetes treatment through fermentation, purification and recovery processes. | Location Clayton |
| |
Company Novo Nordisk Pharmaceutical Industries LP (IFP facility) | Activity: Production and Manufacturing | Company Description Novo Nordisk's Clayton facility manufactures insulin, GLP-1 products and prefilled delivery devices for the treatment of diabetes. | Location Clayton |
| |
Company Praetego Inc. | Activity: Research and Development | Company Description Praetego is preclinical stage pharmaceutical company committed to improving health outcomes by addressing chronic diseases of aging, starting with Alzheimer’s Disease. Praetego’s novel small molecules inhibit a systemic driver of oxidative stress at the initiation of pathology. | Location Research Triangle Park |
| |
Company Roivant Sciences Inc. | Activity: Research and Development | Company Description Roivant Sciences acquires drug candidates or partners with the biopharma industry to complete the clinical development of shelved product candidates. Therapeutic areas include neurology, dermatology, hepatology, oncology, endocrinology and rare disease. | Location Durham |
| |
Company VitriStor LLC | Activity: Research and Development | Company Description VitriStor is developing a technology to produce hepatocytes (liver cells) from cryopreserved livers. | Location Charlotte |
| |
Company Vogenx Inc. | Activity: Research and Development | Company Description Vogenx is a clinical stage pharmaceutical company developing a molecule to address post-bariatric hypoglycemia. | Location Durham |
| |
Company vTv Therapeutics LLC | Activity: Research and Development | Company Description vTv Therapeutics is a clinical-stage biopharmaceutical company developing orally administered small molecule drug candidates to fill significant unmet medical needs in Alzheimer's disease (AD), diabetes and inflammatory disorders. | Location High Point |
| |
Company Xenobiotic Detection Systems International Inc. | Activity: Contract Research and Testing | Company Description Xenobiotic Detection Systems offers patented bioassays to facilitate assessment of environmental and human health risks. | Location Durham |
| |
Company Zenomics Inc. | Activity: Research and Development | Company Description Zenomics is developing a microneedle transdermal patch technology for diabetes, which is able to sense blood glucose levels and respond with appropriate concentrations of insulin. | Location Durham |